The emerging field of immuno-oncology is centered on utilizing the immune system's own defenses against tumors. Among these methods, inhibiting MAGEA3 with targeted antibodies holds significant promise. MAGEA3, a part https://lorignuv115561.activoblog.com/52111860/unlocking-magea3-guide-to-targeting-magea3-immune-responses